Frequently Asked Questions on MLS Laser Therapy

 

What is MLS?

MLS stands for Multi-wave Lock System. MLS is the name of the technology used that utilizes the patented combination of wavelenghts.

 

Is MLS Laser Therapy approved by the FDA?

Yes, the FDA has approved the use of MLS Laser Therapy and it is also patented via the U.S. Patent Office.

 

What are the most common indications for therapy?

The most common MLS Laser Therapy indications are pain relief, intervertebral disc disease, degenerative joint disease, arthritic conditions, muscular/skeletal system trauma, and inflammatory conditions.

 

What is the depth of penetration of the MLS laser?

The depth of penetration varies due to tissue type, but it will penetrate 4-5 cm in most cases.

 

How many treatments are usually needed to get results?

Results can often been seen after the first treatment. Most conditions have protocols that range from 6-10 treatments. The treatments are cumulative and are delivered 2-3 times per week for 2-3 weeks.

 

What wavelengths are used in the MLS Laser Therapy?

MLS Laser Therapy uses both the 808nm and 905 nm wavelengths simultaneously. The 808nm wavelength is delivered using continuous emission while the 905 nm wavelength is delivered using pulsed emission.

 

What is the advantage of MLS Laser Therapy over traditional low-level lasers (LLLT)?

MLS Laser Therapy is able to induce strong anti-inflammatory, anti-edema, and analgesic effects simultaneously and within a short period of time. LLLT cannot achieve these results because of the limitations of using one or two wavelengths that are not synchronized. The patented control system that generates the MLS pulse synchronizes the emissions to achieve results previously unattainable. Thanks to this characteristic synchronization, the various therapeutic effects not only take place at the same time but reciprocally reinforce each other.